Considerations about Non-Metastatic Bladder Cancer Management During the COVID-19 Pandemic

Bladder cancer is the sixth most common malignancy in the United States and is associated with high morbidity and mortality rates. To date, no guidelines have been published that clearly establish bladder cancer management recommendations during the COVID-19 pandemic. In this short commentary, we strive to outline recommendations for treatment of both muscle invasive and non-muscle invasive disease based on data from various trials and prior studies while taking into account the potential lack of hospital resources available to physicians depending on their practice location.